Conacid

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Conacid

Understanding Conacid

Conacid is a pharmacological agent primarily classified as an antacid and mucosal protectant. It is formulated to manage symptoms associated with gastric hyperacidity and various inflammatory conditions of the upper gastrointestinal tract.

Composition and Mechanism of Action

The therapeutic effect of Conacid is achieved through a combination of active ingredients, typically including aluminum hydroxide, magnesium hydroxide, and simethicone. These components work through distinct but complementary pathways:

  • Acid Neutralization: The aluminum and magnesium salts act as weak bases. When they enter the stomach, they react chemically with gastric hydrochloric acid to neutralize it, thereby increasing the pH level of the stomach contents. This reduction in acidity helps alleviate the burning sensation often associated with indigestion.
  • Mucosal Protection: Beyond neutralization, the compound helps form a physical barrier or coat over the gastric and esophageal lining. This protective layer helps shield sensitive tissues from the irritating effects of acid and pepsin.
  • Gas Reduction: The inclusion of simethicone acts as an anti-foaming agent. It works by altering the surface tension of gas bubbles in the stomach and intestines, allowing them to coalesce and be eliminated more easily, which addresses symptoms of bloating and pressure.

Clinical Applications

Conacid is utilized in various clinical scenarios where the regulation of gastric acid is necessary for symptomatic relief. These conditions include:

  • Gastritis: Inflammation of the stomach lining.
  • Peptic Ulcer Disease: Assisting in the management of discomfort while the mucosal lining recovers.
  • Gastroesophageal Reflux: Addressing the symptoms caused by the backflow of stomach acid into the esophagus.
  • Dyspepsia: General upper abdominal discomfort or indigestion.

Physical Characteristics

Conacid is commonly available in several formulations to suit different patient needs, including oral suspensions and chewable tablets. The suspension form is often preferred for its ability to provide rapid coverage of the gastric mucosa, while tablets offer a portable alternative for symptom management.

What side effects are possible with Conacid?

Possible Side Effects and Safety Information

The safety profile of Conacid (mapped to the Proton Pump Inhibitor class based on its therapeutic uses) is defined by officially recognized frequency classifications and system-organ groupings documented by government regulatory bodies.

Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized based on the expected rate of occurrence. Common effects, reported in adult clinical trials, typically include headache, diarrhea, abdominal pain, nausea, and flatulence. Uncommon effects may involve skin reactions like rash and pruritus (itching), insomnia, or dizziness.

Safety Considerations and Serious Reactions

Side effects are grouped by the affected body system, primarily involving Gastrointestinal Disorders, Nervous System Disorders, and Skin and Subcutaneous Tissue Disorders. Serious adverse reactions officially documented in regulatory labeling include Acute Tubulointerstitial Nephritis (a form of kidney inflammation), severe cutaneous adverse reactions (SCARs), Anaphylactic Shock, and Hypomagnesemia (low magnesium levels).

Duration-Related and Population-Specific Notes

Safety concerns are associated with the duration of exposure. Long-term use (typically one year or more) is formally linked to an increased risk of bone fractures of the hip, wrist, or spine, and potential Vitamin B12 deficiency. The label notes specific considerations for patients with severe hepatic impairment and an increased fracture risk observed in older adults. The medicine is contraindicated in individuals with a known hypersensitivity to the active substance or related compounds.

Overdose and Emergency Response

Official regulatory documents classify Folic Acid (Conacid) as relatively nontoxic in man, and no specific antidote is known for acute overdose; management remains symptomatic and supportive. However, official labeling highlights two critical areas of risk and required emergency action.

Severe Risk and Urgent Action

The primary safety warning concerns patients with undiagnosed pernicious anemia (Vitamin B12 deficiency). Administration of high doses may mask the hematologic signs of this deficiency, which allows severe, irreversible nervous system damage to progress. This requires close medical supervision and the administration of Vitamin B12 (Cobalamin) to halt neurological progression.

Immediate medical attention is strictly mandated for signs of allergic sensitization or a severe reaction. This includes manifestations like erythema, skin rash, itching, respiratory difficulty, or symptoms suggesting anaphylaxis. In the event of an accidental overdose, regulatory guidance requires calling a doctor or Poison Control Center immediately.

Documented Manifestations

Symptoms documented in labeling at high daily doses (e.g., 15 mg) include non-specific effects on the gastrointestinal system (nausea, abdominal distention, bitter taste) and the Central Nervous System (altered sleep patterns, irritability, mental depression, confusion, and impaired judgment). An increased incidence of seizures is noted in some epileptic patients as a population-specific consideration.

Therapeutic Uses of Conacid

Quick Facts

  • Relief of symptoms associated with gastroesophageal reflux disease (GERD).
  • Healing of erosive damage to the esophagus caused by acid reflux.
  • Management of conditions where the stomach produces excess acid, such as Zollinger-Ellison syndrome.
  • Treatment of ulcers in the stomach and small intestine.

What Conacid Treats: Main Uses and Benefits

Conacid is an established agent used to manage conditions related to the overproduction of stomach acid. Its primary therapeutic role involves reducing the amount of acid the stomach makes, which provides a path to symptom relief and healing.

The medication is used to provide relief for symptoms related to gastroesophageal reflux disease (GERD). GERD is a common condition where stomach acid moves back into the esophagus, which may result in discomfort and irritation. Conacid helps by decreasing the frequency and severity of these symptoms, allowing for an improved quality of life.

Furthermore, Conacid is a component of treatment regimens aimed at healing erosive esophagitis, which refers to damage to the esophageal lining caused by sustained acid exposure. This action is important in preventing further complications. The medication is also utilized to facilitate the healing of gastric (stomach) and duodenal (small intestine) ulcers and is a key part of combination therapy to manage ulcers associated with Helicobacter pylori (H. pylori) bacteria.

In addition, Conacid is used in the long-term management of conditions characterized by excessive acid secretion, such as Zollinger-Ellison syndrome.

Eligibility and Restrictions for Use

Who Can and Cannot Use Conacid? Official Regulatory Eligibility

The eligibility profile for Conacid (Folic Acid) is defined by strict regulatory guidelines detailing who is permitted, restricted, or prohibited from using the medicine.


Contraindications and Restrictions

Conacid is contraindicated for use in patients with a known history of hypersensitivity or allergic reaction to the active ingredient or any component of the formulation.

A critical restriction exists for individuals with megaloblastic anemia. Conacid must not be used as a standalone treatment if Vitamin B12 deficiency has not been ruled out. This conditional prohibition is in place because Folic Acid may mask the blood-related symptoms of pernicious anemia, allowing irreversible neurological damage associated with B12 deficiency to progress. Use for this condition is restricted to situations where coexisting Vitamin B12 deficiency is managed concurrently.


Approved Populations

Official labeling confirms that Conacid is permitted and established for use across all major life stages. This includes infants, children, adolescents, adults, and older adults for appropriate indications. Furthermore, regulatory classification designates use during pregnancy and lactation as permitted and recommended (Pregnancy Category A). No specific dose adjustments or use limitations are mandated based on renal or hepatic impairment status.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Conacid (Folic Acid) interaction data, based on official regulatory documentation, primarily describes conflicts that affect the systemic exposure or therapeutic action of co-administered medicines.


Documented Pharmacological Conflicts

Mechanism Interacting Substances Official Interaction Statement
Pharmacodynamic Methotrexate, Pyrimethamine, Trimethoprim Folic Acid may reduce the anti-folate effect and overall therapeutic efficacy of these agents via antagonism.
Exposure Alteration Phenytoin, Phenobarbital, Primidone Co-administration has been reported to decrease the plasma concentration of these anticonvulsant drugs.
Absorption Interference Sulfasalazine, Cholestyramine, Antacids These substances may interfere with and reduce the proper uptake and absorption of Folic Acid.

Administration Constraints

Certain official constraints govern the use of Conacid with other products to ensure proper absorption and efficacy. Regulatory documents state that Folic Acid administration must be separated from Cholestyramine by one hour before or four to six hours after co-administration. Additionally, Antacids should be taken at least two hours after Folic Acid to avoid interference with its absorption. Regarding substances, excessive alcohol consumption is documented as a factor that may reduce serum folate concentrations and increase elimination. Co-administration of high-dose Folic Acid with Fluorouracil is subject to warnings due to the potential for severe diarrhea.

Mechanism of Action

The mechanism of Folic Acid (Conacid) operates through its role as an essential metabolic precursor. Conacid is inactive until it is enzymatically reduced, primarily by Dihydrofolate Reductase (DHFR), into its active coenzyme forms. These coenzymes act as vital one-carbon donors required for the synthesis of purine and deoxythymidylate (dTMP) bases, which are essential for the accurate construction and replication of genetic material in highly proliferative tissues. By enabling DNA production, the mechanism facilitates the successful completion of the cell division cycle. This action is crucial in the hematopoietic system, where the sufficient provision of cofactors is required for the successful nuclear maturation of blood cell precursors, influencing the morphology and promoting the appropriate size and maturation of red blood cells. Furthermore, active folate is integral to the methionine-homocysteine cycle, working with Methionine Synthase to remethylate homocysteine. This pathway is essential for generating S-adenosylmethionine (SAM), a required methyl donor for numerous metabolic reactions, including those necessary for the synthesis and maintenance of nervous system components.

Dosage and Administration Information

The administration of Conacid (Folic Acid) follows a standardized protocol. The oral tablet is the preferred route of administration, while parenteral use (Intramuscular, Intravenous, or Subcutaneous) is reserved for cases involving severe disease or known impaired gastrointestinal absorption.

Dosing is governed by the phase of use. For active therapeutic use, the standard regimen for addressing megaloblastic anemia is typically up to 1 mg daily. Once the patient’s clinical status is normalized, the treatment transitions to a lower, continued maintenance dose, commonly 0.4 mg daily for adults. All doses are generally administered once daily. Specific protocols exist for high-risk groups; for instance, high-risk prophylaxis for women planning conception may require doses up to 5 mg daily, which should begin before pregnancy and continue through the first trimester.

Procedural constraints must be followed for all forms. The injectable solution must be visually inspected for particulate matter before use, and when given intravenously, the administration must be performed slowly, over at least one minute. Additionally, the injectable solution must be stored protected from light. If a daily dose is missed, instructions mandate that the dose must not be doubled to compensate.

Recent Clinical Evidence

Conacid: Recent Clinical Evidence

Efficacy in Acute Migraine

Studies have explored the drug's role in the management of acute migraine headaches. Trials generally involve patients experiencing moderate to severe migraine attacks. Primary clinical research has focused on the proportion of patients who achieved pain-free status two hours post-dose, often used as a primary endpoint.

  • A key meta-analysis evaluated quantitative changes in headache severity and researchers explored whether this was associated with the time taken to return to daily activities.
  • Secondary endpoints included evaluation of sustained pain-free response up to 24 or 48 hours. Results evaluating differences from placebo were variable across time points.

Treatment Pathway and Investigation

Studies involved investigation of interaction with the calcitonin gene-related peptide (CGRP) receptor (its target). Researchers evaluated the pharmacokinetics and pharmacodynamics of the drug, particularly its high affinity for this receptor.

  • Research explored associations between this treatment pathway and subsequent medication overuse headache events in certain patient groups.
  • Studies exploring long-term comparisons to older treatments are ongoing.

Safety and Patient Populations

Safety studies examined the use in various patient populations, including those with cardiovascular disease, particularly regarding combination therapies. Commonly reported side effects include dizziness, nausea, and dry mouth.

  • Research also evaluated whether co-administration with other acute migraine treatments (such as triptans) influenced the overall side effect profile.
  • Future research is exploring the drug’s role in chronic migraine management, and the overall impact on quality of life is currently being evaluated in larger, ongoing registries.

Frequently Asked Questions (FAQ)

Common questions about Conacid (FAQ)

Q: Is Conacid the same as other medicines for the same condition?

A: Conacid contains the active ingredient Folic Acid, which is formally classified as a water-soluble vitamin and hematopoietic agent. Regulatory documents state that its use is restricted if a coexisting deficiency of Vitamin B12 has not been ruled out. This conditional prohibition exists because Folic Acid may mask the blood-related symptoms of pernicious anemia.

Q: How long does it typically take for Conacid to start working?

A: According to official product information, the active ingredient is absorbed relatively quickly after taking the oral dose, generally reaching peak levels within about an hour. For the treatment of deficiency, early signs of a response in the bone marrow are typically observed clinically within the first 48 hours. A measured rise in blood cell markers (reticulocytes) is documented to begin within 2 to 5 days of treatment.

Q: Can Conacid be taken with general pain relievers like Tylenol (acetaminophen)?

A: Official guidance from regulatory-linked sources states that Folic Acid can be taken at the same time as common everyday pain relievers such as paracetamol (acetaminophen).

Q: Is it normal to feel a bit tired after taking Conacid?

A: Tiredness or fatigue is not listed as a common or uncommon side effect of the medicine itself in regulatory documents. However, general weakness or discomfort is reported rarely in official product information. It is also noted that fatigue is a recognized symptom associated with the underlying condition of folate deficiency.

Q: Does Conacid have any known interactions with common herbal supplements?

A: Official guidance notes that the active ingredient may interact with certain nutritional supplements. Regulatory-linked sources provide an example that Folic Acid can interfere with the absorption and proper functioning of zinc supplements.

Q: Is Conacid safe for use in older adults?

A: Official documentation states that problems in older adults have not been reported with the intake of normal daily recommended amounts. However, Folic Acid is conditionally restricted if Vitamin B12 deficiency has not been ruled out. This is due to a documented risk that Folic Acid may obscure neurological damage in older adults with low B12 status.

Q: Are there any food or drinks that should be avoided while using Conacid?

A: The official product information documents that excessive consumption of alcohol is a factor that may reduce the body’s absorption of the active ingredient and increase its elimination. No specific common food is required to be avoided.

Q: I'm taking an antidepressant; are there any concerns with also using Conacid?

A: Specific interactions with the class of antidepressant medicines are not listed in official documentation. However, high doses of the active ingredient have been rarely associated with Central Nervous System effects. These effects include mental depression, excitement, confusion, and impaired judgment.

Q: Can people with a history of kidney issues use Conacid?

A: Regulatory documents note that individuals with kidney disease who are undergoing haemodialysis may have an increased need for the vitamin. Official labeling does not mandate specific dose adjustments or use limitations based on renal impairment status.

Q: Does Conacid cause changes in body weight?

A: Changes in body weight are not listed as an adverse reaction to the medicine itself in official safety information. However, weight loss is a documented symptom associated with the underlying condition of folate deficiency.

Q: Is Conacid available without a prescription?

A: The active ingredient, Folic Acid, is widely available as an over-the-counter (OTC) supplement. However, certain high strengths or specific formulations are only available with a prescription.

Q: Does Conacid impact blood pressure or heart rate?

A: Impacts on blood pressure or heart rate are not listed as a side effect of the medicine itself in official safety documentation. However, a fast heartbeat (tachycardia) is listed as a documented symptom of the underlying condition of folate deficiency.

Q: Are there different strengths or formulations of Conacid?

A: The product is officially available as an oral tablet and a specialized injectable solution for use in clinical settings. The tablets are supplied in various strengths and are prescribed depending on the therapeutic goal.

Q: Are there any specific lifestyle changes recommended alongside Conacid?

A: Official guidance mentions that maintaining a balanced diet, especially one rich in B vitamins, and consuming alcohol in moderation are relevant factors when addressing vitamin status. These factors support the body’s metabolic functions and the intended therapeutic goal of the medicine.

Q: Does taking Conacid at a certain time of day matter?

A: The official instructions indicate that dosing is generally administered once daily. Regulatory documents do not mandate a specific time of day (morning versus evening). Official product information notes that taking the dose with food may help if stomach upset is experienced.

Q: Is the effect of Conacid supposed to last all day?

A: The dosage is typically administered once daily, which aligns with the required daily provision to maintain necessary metabolic functions. The active substance is rapidly absorbed and utilized by the body to support cellular processes throughout the day.

Q: Does Conacid interfere with the effectiveness of birth control pills?

A: Official regulatory guidance states that the active ingredient, Folic Acid, will not stop any type of contraception from working. This includes both the combined and progestogen-only birth control pills.

Q: Are there specific symptoms that mean Conacid is working?

A: Official documentation focuses on clinical markers of efficacy. In the treatment of deficiency, the bone marrow begins to become normoblastic (normal) within the first 48 hours, and a rise in blood cell markers (reticulocytes) begins within 2 to 5 days.

Q: Can Conacid cause changes in mood or anxiety?

A: The active ingredient in high doses (e.g., in high doses) have been rarely associated with Central Nervous System effects. These can include mental depression, excitement, confusion, and irritability. These effects are based on rare reports from high intake.

Q: What is the maximum amount of time a person can safely use Conacid?

A: The active ingredient is relatively non-toxic, and there is no formal maximum duration of use stated for the lower maintenance dose. However, regulatory documents stress that certain higher therapeutic doses require that a Vitamin B12 deficiency is fully ruled out prior to administration.

Q: Is it true that Conacid should be taken on an empty stomach?

A: The official instructions are generally non-directive regarding timing with meals. There is no requirement to take the medicine on an empty stomach. Official product information notes that taking the dose with food may help if stomach upset is experienced.

Q: Does Conacid affect the liver in any way?

A: The active substance is primarily metabolized in the liver as part of its conversion into active coenzyme forms. Official documentation notes specific considerations regarding the use of the medicine in patients with severe hepatic impairment.

Q: Can I use Conacid if I am allergic to similar types of medicines?

A: The product is officially contraindicated for use in patients with a known hypersensitivity to the active substance. The official label notes that all known allergies, including sensitivities to other medicines and foods, are relevant for consideration during the prescribing process.

Q: How long does Conacid stay in the system after the last intake?

A: The active substance is rapidly absorbed and undergoes immediate metabolism in the liver. Its elimination is documented to be increased by factors like alcohol. A precise half-life is not specified in patient-facing regulatory materials.

Q: Is Conacid meant for short-term use, or is it a long-term medicine?

A: The product has official roles in both short-term and long-term use. Initial doses are for active therapeutic use to treat a deficiency. This is followed by a lower, continued maintenance dose to sustain the body’s metabolic functions over time.

Q: Are there common signs of too much Conacid being in the body?

A: Symptoms associated with high daily intake (e.g., high daily intake) have been reported to include digestive disturbances such as nausea and abdominal pain. Central Nervous System effects such as trouble sleeping, irritability, and confusion have also been reported.

Q: Is it okay to crush or cut Conacid tablets?

A: Folic acid tablets may be physically suitable for crushing or dispersing in liquid. Crushing or dispersing is sometimes performed for patients with swallowing difficulties. This practice is typically managed with oversight from a healthcare professional.

Q: Is Conacid a proton pump inhibitor (PPI)?

A: No. Official regulatory documents classify the active ingredient, Folic Acid, as a water-soluble B complex Vitamin and a Hematopoietic Agent. It does not belong to the pharmacological class of Proton Pump Inhibitors.

How should Conacid be stored and disposed of?

How to Store and Dispose of Conacid?

The storage and disposal of Conacid (Folic Acid tablets) must strictly follow official regulatory guidelines to maintain potency and safety.

Storage Conditions

Conacid must be kept at controlled room temperature, typically 20 C to 25 C. The product must be protected from moisture and humidity by ensuring the container is tightly closed and stored in its original container. The tablets must not be refrigerated or frozen. To prevent accidental ingestion, always store Conacid out of the reach and sight of children.

Disposal Instructions

Unused or expired Conacid must be disposed of according to local regulations or by utilizing an approved drug take-back program. The medicine should not be discarded in household trash, thrown into wastewater, or flushed down the toilet unless specifically authorized by the product labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Conacid found in:

A-Z Index: